Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update

Biomerica, Inc. (NASDAQ:BMRA) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 52,200 shares, a drop of 27.5% from the July 31st total of 72,000 shares. Based on an average trading volume of 78,700 shares, the short-interest ratio is currently 0.7 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Perritt Capital Management Inc bought a new stake in Biomerica during the second quarter worth approximately $31,000. Russell Investments Group Ltd. boosted its holdings in Biomerica by 11.8% during the first quarter. Russell Investments Group Ltd. now owns 225,435 shares of the company’s stock worth $188,000 after buying an additional 23,872 shares in the last quarter. Finally, Fore Capital LLC boosted its holdings in Biomerica by 72.1% during the first quarter. Fore Capital LLC now owns 59,680 shares of the company’s stock worth $50,000 after buying an additional 25,000 shares in the last quarter. 22.28% of the stock is currently owned by institutional investors.

Biomerica Price Performance

Shares of Biomerica stock traded down $0.02 on Friday, hitting $0.44. The company had a trading volume of 75,308 shares, compared to its average volume of 144,210. The business has a 50-day simple moving average of $0.38 and a 200-day simple moving average of $0.65. The company has a market cap of $7.40 million, a PE ratio of -1.19 and a beta of -1.08. Biomerica has a 52 week low of $0.24 and a 52 week high of $2.13.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.